Nutex Health
(NASDAQ) NUTX
Nutex Health Financials at a Glance
Market Cap
$869.11M
Revenue (TTM)
$879.95M
Net Income (TTM)
$96.38M
EPS (TTM)
$12.95
P/E Ratio
9.75
Dividend
$0.00
Beta (Volatility)
1.41 (Average)
Dividend
$0.00
Beta (Volatility)
1.41 (Average)
Price
$126.59
Volume
98,116.21
Open
$125.24
Price
$126.59
Volume
98,116.21
Open
$125.24
Previous Close
$126.30
Daily Range
$121.19 - $127.31
52-Week Range
$77.21 - $193.07
Dividend
$0.00
Beta (Volatility)
1.41 (Average)
Price
$126.59
Volume
98,116.21
Open
$125.24
Previous Close
$126.30
Daily Range
$121.19 - $127.31
52-Week Range
$77.21 - $193.07
NUTX News
NUTX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Nutex Health
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
1,005
CEO
Thomas T. Vo, MD, MBA
Website
www.nutexhealth.comHeadquarters
Houston, TX 77081, US
NUTX Financials
Key Financial Metrics (TTM)
Gross Margin
47%
Operating Margin
31%
Net Income Margin
11%
Return on Equity
37%
Return on Capital
36%
Return on Assets
10%
Earnings Yield
10.26%
Dividend Yield
0.00%
Payout Ratio
36.12%
Stock Overview
Market Cap
$869.11M
Shares Outstanding
6.88M
Volume
98.12K
Avg. Volume
193.26K
Financials (TTM)
Gross Profit
$444.28M
Operating Income
$275.63M
EBITDA
$287.54M
Operating Cash Flow
$248.13M
Capital Expenditure
$2.53M
Free Cash Flow
$245.60M
Cash & ST Invst.
$185.57M
Total Debt
$351.39M
Nutex Health Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$216.49M
+2.2%
Gross Profit
$91.73M
-22.5%
Gross Margin
42.37%
N/A
Market Cap
$869.11M
N/A
Market Cap/Employee
$1.09M
N/A
Employees
800
N/A
Net Income
$46.81M
+219.9%
EBITDA
$86.73M
+17.2%
Quarterly Fundamentals
Net Cash
$141.74M
+44.8%
Accounts Receivable
$339.56M
+13.4%
Inventory
$4.68M
+50.1%
Long Term Debt
$322.67M
+3.9%
Short Term Debt
$26.41M
-14.5%
Return on Assets
10.07%
N/A
Return on Invested Capital
35.74%
N/A
Free Cash Flow
$74.32M
+46.0%
Operating Cash Flow
$75.52M
+48.2%